Exicure (XCUR) Other Non-Current Liabilities (2016 - 2026)
Exicure's (XCUR) quarterly Other Non-Current Liabilities came in at $5.8 million in Q1 2026, up 7.28% YoY from $5.4 million in Q1 2025, and down 0.52% on a QoQ basis from $5.8 million in Q4 2025.
Exicure (XCUR) Other Non-Current Liabilities (2016 - 2026) Analysis & Trends
Exicure (XCUR) has 8 years of Other Non-Current Liabilities data on file, last reported at $5.8 million in Q1 2026.
- Quarterly Other Non-Current Liabilities rose 7.28% year-over-year to $5.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.8 million (up 7.28% YoY) and the FY2025 annual result came in at $5.8 million, changed N/A from the prior year.
- Other Non-Current Liabilities declined to $5.8 million in Q1 2026, from $5.8 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $5.8 million in Q4 2025 to a low of $5.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Exicure | 7.27 Mn | 7.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.77 Mn |
| Dec 31, 2025 | 5.80 Mn |
| Sep 30, 2025 | 5.55 Mn |
| Jun 30, 2025 | 5.31 Mn |
| Mar 31, 2025 | 5.38 Mn |
| Dec 31, 2021 | 656,000.00 |
| Sep 30, 2021 | 656,000.00 |
| Jun 30, 2021 | 656,000.00 |
| Mar 31, 2021 | 656,000.00 |
| Dec 31, 2020 | 656,000.00 |
| Sep 30, 2020 | 656,000.00 |
| Sep 30, 2019 | 144,000.00 |
| Jun 30, 2019 | 226,000.00 |
| Mar 31, 2019 | 380,000.00 |
| Dec 31, 2018 | 39,000.00 |
| Sep 30, 2018 | 42,000.00 |
| Jun 30, 2018 | 275,000.00 |
| Mar 31, 2018 | 277,000.00 |
| Dec 31, 2017 | 278,000.00 |
| Dec 31, 2016 | 281,000.00 |